Long acting follicle stimulating hormone versus daily follicle stimulating hormone for women undergoing assisted reproduction

We conducted a systematic review of the use of long acting versus daily follicle-stimulating hormone for women undergoing assisted reproduction.

Like Comment

Authors

Annefloor W. Pouwer, M.Sc., Cynthia Farquhar, M.P.H., Jan A.M. Kremer, Ph.D., Jane Marjoribanks, M.P.H.

Volume 105, Issue 6, Pages 1454-1456

Abstract

Follicle-stimulating hormone (FSH) given as a weekly injection in a medium dose is as safe and effective as a daily FSH injection for women undergoing assisted reproduction.

Read the full text at: http://fertstertforum.com/pouwera-long-acting-versus-daily-fsh-art/


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility┬« is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.